Follow
Efficacy and Safety of Viltolarsen in Boys With Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study. https://content.iospress.com/articles/journal-of-neuromuscular-diseases/jnd221656
#Morpholino
